Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sunniva Inc SNNVF

Healthcare Biotechnology Cannabis
Sunniva Inc. is a Canada-based company. The Company is not engaged in any business.


GREY:SNNVF - Post by User

Sunniva Inc > Agreed its a good buy for a very high risk investor. Have to
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Mac2676on Dec 04, 2019 3:16pm
171 Views
Post# 30422147

RE:RE:Agreed its a good buy for a very high risk investor. Have to

RE:RE:Agreed its a good buy for a very high risk investor. Have toNever go to Zero? Don't kid yourself As an investor who has seen and been a part of a couple of speculative companies that had potential both of them are worthless.  I keep them as listings in my portfolio to remind myself that stocks can be worthless.  Remeber Enron and Nortel?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities